Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
240.00
Ask:
0.00
Spread: 10.00 (4.167%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Board Changes

12 Dec 2008 11:00

RNS Number : 0326K
Gleeson(M J)Group PLC
12 December 2008
 



12 December 2008

M J GLEESON GROUP PLC

Board Changes

Resignation of Paul Wallwork as Group Chief Executive

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces the resignation of Paul Wallwork as Group Chief Executive with effect from 31 December 2008

Paul Wallwork, ACA, BA (Hons), 46, was appointed to the Board in January 2006 as Group Finance Director. He was appointed Group Chief Executive in January 2007 having previously served as Interim Group Chief Executive since July 2006. He previously held senior financial and management roles with Inchcape plc and senior financial roles with Brent International plc.

Dermot Gleeson, Non-executive Chairman, stated "I would like to thank Paul for his strong and energetic leadership of the Gleeson Group through an extremely challenging period. He has ensured that the Group is well placed to meet the tough challenges faced by all housebuilders in the current market conditions."

Appointment of Group Chief Executive

Gleeson is pleased to announce the appointment as Group Chief Executive, with effect from 1 January 2009, of Chris Holt who, since 1 May 2007, has been Group Finance Director and prior to that held the position of Interim Group Finance Director from August 2006.

Nicholas Christopher Holt, BSc, MBA, CIMA, 57, has obtained a wealth of financial and management experience at senior level with internationally renowned businesses, namely Foster Wheeler (1987-2005) and Bechtel (1975-87). 

Dermot Gleesonstated "As Group Finance Director, Chris has made a hugely important contribution to the successful restructuring of the Group, and his skills and experience mean that he is very well equipped to provide the effective leadership that Gleeson will continue to need in an exceptionally difficult economic environment."

Appointment of Group Finance Director

To replace Chris Holt, Gleeson is pleased to announce the appointment of Alan Martin as Group Finance Director with effect from 1 January 2009. Alan is currently Group Financial Controller, a position he has held since November 2006.

Alan Martin, BSc (Hons), ACA, 42, qualified as a Chartered Accountant in 1990, following which he joined Price Waterhouse where he specialised in corporate recovery in both London and SydneyAustralia. Assignments included secondment as Advisor to National Australia Bank. In 2000, he joined Psion PLC, where he held a number of senior management roles, the most recent being Group Financial Controller.

Alan Martin has held no directorship in any other publicly quoted company at any time in the previous five years and there are no details to be disclosed under paragraph 9.6.13 R of the Listing Rules.

Dermot Gleeson stated "I am delighted that Alan has joined the Board to which he has the potential to make an extremely valuable contribution." 

Enquiries:

M J Gleeson Group plc 01252 360300

Chris Holt (Group Chief Executive, Designate)

Alan Martin (Group Finance Director, Designate)

Bankside Consultants Limited

Charles Ponsonby  020 7367 8851

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFKBKNKBDDFBD
Date   Source Headline
7th Jan 20217:00 amRNSDirector/PDMR Shareholding
31st Dec 20207:00 amRNSTotal Voting Rights
9th Dec 20205:54 pmRNSDirector/PDMR Shareholding
3rd Dec 20201:44 pmRNSResult of AGM
3rd Dec 20207:00 amRNSAGM Statement
30th Nov 20207:00 amRNSTotal Voting Rights
19th Nov 20209:50 amRNSDirector/PDMR Shareholding
10th Nov 20206:15 pmRNSDirector/PDMR Shareholding
3rd Nov 20207:00 amRNSNotice of AGM
30th Oct 20207:00 amRNSTotal Voting Rights
22nd Oct 20203:01 pmRNSDirector/PDMR Shareholding
9th Oct 20202:25 pmRNSDirector/PDMR Shareholding
30th Sep 20207:00 amRNSTotal Voting Rights
25th Sep 20209:48 amRNSPerformance Share Plan Award to Directors/PDMRs
16th Sep 202012:46 pmRNSDirector/PDMR Shareholding
14th Sep 20207:00 amRNSFinal Results
9th Sep 20201:18 pmRNSDirector/PDMR Shareholding
28th Aug 20207:00 amRNSTotal Voting Rights
6th Aug 20205:29 pmRNSDirector/PDMR Shareholding
31st Jul 20207:00 amRNSTotal Voting Rights
17th Jul 20207:00 amRNSLong Term Incentive Plan Award
9th Jul 20207:00 amRNSTrading Update
8th Jul 20209:42 amRNSDirector/PDMR Shareholding
2nd Jul 202012:07 pmRNSSecond Price Monitoring Extn
2nd Jul 202012:02 pmRNSPrice Monitoring Extension
30th Jun 20207:00 amRNSTotal Voting Rights
15th Jun 20207:00 amRNSTrading Update
9th Jun 202010:29 amRNSDirector/PDMR Shareholding
29th May 20207:00 amRNSTotal Voting Rights
22nd May 20207:00 amRNSCommittee Appointments
18th May 202012:07 pmRNSSecond Price Monitoring Extn
18th May 202012:02 pmRNSPrice Monitoring Extension
14th May 20207:00 amRNSReopening of sites and sales offices
7th May 20209:52 amRNSDirector/PDMR Shareholding
30th Apr 20207:00 amRNSTotal Voting Rights
28th Apr 20205:24 pmRNSDisclosure of Rights attached to Listed Securities
28th Apr 20204:42 pmRNSDirector/PDMR Shareholding
9th Apr 20201:32 pmRNSNotification of Transactions by Directors / PCA
8th Apr 20206:14 pmRNSDirector/PDMR Shareholding
8th Apr 20201:16 pmRNSResults of Placing
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSProposed Placing of New Shares
6th Apr 20207:00 amRNSCovid-19 Update
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202012:07 pmRNSSecond Price Monitoring Extn
1st Apr 202012:02 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSTotal Voting Rights
30th Mar 20204:13 pmRNSCompany Secretary Change
25th Mar 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.